Clinical Trial Update: First-in-Human Study of CLS003 ICVT in Subjects With Cutaneous Warts [Phase 1, Phase 2]

View source ↗

Summary

This update reports the completion of a first-in-human Phase 1/2 study evaluating CLS003 ICVT for cutaneous warts.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Warts

Drugs mentioned

• CLS003 ICVT

Snippet

Sponsor: Maruho Co., Ltd. | Conditions: Cutaneous Warts | Phase 1, Phase 2 | Status: COMPLETED